Multivariable analysis for participants with previous cerebrovascular ischemic eventsa
| Multivariable | |||
|---|---|---|---|
| OR | 95% CI | P | |
| Age (yr) | 0.99 | 0.91–1.08 | .88 |
| Female | 0.43 | 0.07–2.72 | .37 |
| Active smoker | 7.50 | 1.10–51.47 | .04 |
| Diabetes mellitus | 10.25 | 0.91–115.92 | .06 |
| Hypertension | 0.58 | 0.10–3.34 | .54 |
| Hyperlipidemia | 0.51 | 0.08–3.14 | .47 |
| Statin use | 0.81 | 0.06–9.84 | .87 |
| Aspirin use | 0.99 | 0.10–9.70 | .99 |
| Stenosis (%) | 0.05 | 0.02–1.50 | .09 |
| Maximum wall thickness (mm) | 0.77 | 0.40–1.45 | .42 |
| Adventitial enhancement (category 1 vs category 0) | 14.90 | 0.98–225.93 | .05 |
| Adventitial enhancement (category 2 vs category 0) | 51.17 | 3.40–469.80 | .004 |
| IPH presence | 10.18 | 1.42–72.21 | .02 |
↵a Adjusting for coils and gadolinium dose.